378 related articles for article (PubMed ID: 34625124)
41. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
[TBL] [Abstract][Full Text] [Related]
42. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
Wang Y; Luan Z; Zhao C; Bai C; Yang K
Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia.
Pastorczak A; Domka K; Fidyt K; Poprzeczko M; Firczuk M
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810515
[TBL] [Abstract][Full Text] [Related]
44. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance.
Chen J; Cao X; Li B; Zhao Z; Chen S; Lai SWT; Muend SA; Nossa GK; Wang L; Guo W; Ye J; Lee PP; Feng M
Front Immunol; 2020; 11():621757. PubMed ID: 33603751
[TBL] [Abstract][Full Text] [Related]
45. Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms.
Chen J; Zhang H; Zhou L; Hu Y; Li M; He Y; Li Y
Front Oncol; 2020; 10():584367. PubMed ID: 33614478
[TBL] [Abstract][Full Text] [Related]
46. Coagulation signaling and cancer immunotherapy.
Ruf W; Graf C
Thromb Res; 2020 Jul; 191 Suppl 1():S106-S111. PubMed ID: 32736766
[TBL] [Abstract][Full Text] [Related]
47. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
48. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
[TBL] [Abstract][Full Text] [Related]
49. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
50. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
Yang L; Li A; Lei Q; Zhang Y
J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
[TBL] [Abstract][Full Text] [Related]
51. Targeting macrophages: a novel avenue for cancer drug discovery.
Kumar S; Ramesh A; Kulkarni A
Expert Opin Drug Discov; 2020 May; 15(5):561-574. PubMed ID: 32141351
[No Abstract] [Full Text] [Related]
52. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
53. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
54. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
55. Myeloid suppressor cells in cancer and autoimmunity.
Sica A; Massarotti M
J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
[TBL] [Abstract][Full Text] [Related]
56. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression.
Wang L; Hu YY; Zhao JL; Huang F; Liang SQ; Dong L; Chen Y; Yu HC; Bai J; Yang JM; Fan JY; Feng L; Li SZ; Han H; Qin HY
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948650
[TBL] [Abstract][Full Text] [Related]
57. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
[TBL] [Abstract][Full Text] [Related]
58. Progress in Tumor-Associated Macrophages: From Bench to Bedside.
Wang Y; Lin YX; Qiao SL; Wang J; Wang H
Adv Biosyst; 2019 Feb; 3(2):e1800232. PubMed ID: 32627370
[TBL] [Abstract][Full Text] [Related]
59. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
[TBL] [Abstract][Full Text] [Related]
60. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]